ROMO1 and metastatic malignant neoplasm in the lymph nodes: In the univariate analysis, presence of lymph node metastasis, overall stage, treatment with platinum-based chemotherapy, and romo1 expression were found to be associated with poor DFS (P = 0.012, P = 0.004, P = 0.001 and P = 0.054).